These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

95 related articles for article (PubMed ID: 8389297)

  • 1. Lactotransferrin binding to its platelet receptor inhibits platelet aggregation.
    Leveugle B; Mazurier J; Legrand D; Mazurier C; Montreuil J; Spik G
    Eur J Biochem; 1993 May; 213(3):1205-11. PubMed ID: 8389297
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Study on the binding of lactotransferrin (lactoferrin) to human PHA-activated lymphocytes and non-activated platelets. Localisation and description of the receptor-binding site.
    Mazurier J; Legrand D; Leveugle B; Rochard E; Montreuil J; Spik G
    Adv Exp Med Biol; 1994; 357():111-9. PubMed ID: 7762422
    [TBL] [Abstract][Full Text] [Related]  

  • 3. KRDS, a new peptide derived from human lactotransferrin, inhibits platelet aggregation and release reaction.
    Mazoyer E; Lévy-Toledano S; Rendu F; Hermant L; Lu H; Fiat AM; Jollès P; Caen J
    Eur J Biochem; 1990 Nov; 194(1):43-9. PubMed ID: 2174781
    [TBL] [Abstract][Full Text] [Related]  

  • 4. KRDS--a tetrapeptide derived from lactotransferrin--inhibits binding of monoclonal antibody against glycoprotein IIb-IIIa on ADP-stimulated platelets and megakaryocytes.
    Raha S; Dosquet C; Abgrall JF; Jolles P; Fiat AM; Caen JP
    Blood; 1988 Jul; 72(1):172-8. PubMed ID: 3291978
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Inhibition effects of KRDS, a peptide derived from lactotransferrin, on platelet function and arterial thrombus formation in dogs.
    Wu G; Ruan C; Drouet L; Caen J
    Haemostasis; 1992; 22(1):1-6. PubMed ID: 1381697
    [TBL] [Abstract][Full Text] [Related]  

  • 6. KRDS, a peptide derived from human lactotransferrin, inhibits thrombin-induced thromboxane synthesis by a cyclooxygenase-independent mechanism.
    Lévy-Toledano S; Grelac F; Caen JP; Maclouf J
    Thromb Haemost; 1995 May; 73(5):857-61. PubMed ID: 7482416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelet aggregation and fibrinogen binding in human, rhesus monkey, guinea-pig, hamster and rat blood: activation by ADP and a thrombin receptor peptide and inhibition by glycoprotein IIb/IIIa antagonists.
    Cook NS; Zerwes HG; Tapparelli C; Powling M; Singh J; Metternich R; Hagenbach A
    Thromb Haemost; 1993 Sep; 70(3):531-9. PubMed ID: 8259560
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Molecular interactions between human lactotransferrin and the phytohemagglutinin-activated human lymphocyte lactotransferrin receptor lie in two loop-containing regions of the N-terminal domain I of human lactotransferrin.
    Legrand D; Mazurier J; Elass A; Rochard E; Vergoten G; Maes P; Montreuil J; Spik G
    Biochemistry; 1992 Sep; 31(38):9243-51. PubMed ID: 1327110
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differential inhibition of platelet aggregation induced by adenosine diphosphate or a thrombin receptor-activating peptide in patients treated with bolus chimeric 7E3 Fab: implications for inhibition of the internal pool of GPIIb/IIIa receptors.
    Kleiman NS; Raizner AE; Jordan R; Wang AL; Norton D; Mace KF; Joshi A; Coller BS; Weisman HF
    J Am Coll Cardiol; 1995 Dec; 26(7):1665-71. PubMed ID: 7594101
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The antithrombotic effect of KRDS, a lactotransferrin peptide, compared with RGDS.
    Drouet L; Bal dit Sollier C; Cisse M; Pignaud G; Mazoyer E; Fiat AM; Jolles P; Caen JP
    Nouv Rev Fr Hematol (1978); 1990; 32(1):59-62. PubMed ID: 2349083
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel surface-active peptide derivative exhibits in vitro inhibition of platelet aggregation.
    Ramesh CV; Jayakumar R; Puvanakrishnan R
    Peptides; 1998; 19(10):1695-702. PubMed ID: 9880074
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of common platelet receptors between the chacma baboon (Papio ursinus) and human for use in pre-clinical human-targeted anti-platelet studies.
    Janse van Rensburg WJ
    Platelets; 2016 Jun; 27(4):322-32. PubMed ID: 26559117
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of the specific binding of human lactotransferrin to human peripheral-blood phytohaemagglutinin-stimulated lymphocytes by fluorescein labelling and location of the binding site.
    Legrand D; Mazurier J; Maes P; Rochard E; Montreuil J; Spik G
    Biochem J; 1991 Jun; 276 ( Pt 3)(Pt 3):733-8. PubMed ID: 1648350
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The integrin alpha IIb beta 3 contains distinct and interacting binding sites for snake-venom RGD (Arg-Gly-Asp) proteins. Evidence that the receptor-binding characteristics of snake-venom RGD proteins are related to the amino acid environment flanking the sequence RGD.
    Rahman S; Lu X; Kakkar VV; Authi KS
    Biochem J; 1995 Nov; 312 ( Pt 1)(Pt 1):223-32. PubMed ID: 7492316
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. II. Quantal activation parallels platelet capture in stir-associated microaggregation.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2069-75. PubMed ID: 7858144
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Beta 3 integrin derived peptide 217-230 inhibits fibrinogen binding and platelet aggregation: significance of RGD sequences and fibrinogen A alpha-chain.
    Lasz EC; McLane MA; Trybulec M; Kowalska MA; Khan S; Budzynski AZ; Niewiarowski S
    Biochem Biophys Res Commun; 1993 Jan; 190(1):118-24. PubMed ID: 8422238
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dynamics of platelet glycoprotein IIb-IIIa receptor expression and fibrinogen binding. I. Quantal activation of platelet subpopulations varies with adenosine diphosphate concentration.
    Frojmovic MM; Mooney RF; Wong T
    Biophys J; 1994 Nov; 67(5):2060-8. PubMed ID: 7858143
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The N-terminal domain I of human lactotransferrin binds specifically to phytohemagglutinin-stimulated peripheral blood human lymphocyte receptors.
    Rochard E; Legrand D; Mazurier J; Montreuil J; Spik G
    FEBS Lett; 1989 Sep; 255(1):201-4. PubMed ID: 2551729
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential effects of extra- and intracellular calcium chelation on human platelet function and glycoprotein IIb-IIIa complex stability.
    Lanza F; Stierlé A; Gachet C; Cazenave JP
    Nouv Rev Fr Hematol (1978); 1992; 34(1):123-31. PubMed ID: 1523093
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.